Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.44%.

  • Ptc Therapeutics' Return on Capital Employed rose 5400.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 5400.0%. This contributed to the annual value of 0.25% for FY2024, which is 1200.0% up from last year.
  • Per Ptc Therapeutics' latest filing, its Return on Capital Employed stood at 0.44% for Q3 2025, which was up 5400.0% from 0.36% recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Return on Capital Employed ranged from a high of 0.45% in Q1 2025 and a low of 0.8% during Q3 2023
  • For the 5-year period, Ptc Therapeutics' Return on Capital Employed averaged around 0.21%, with its median value being 0.26% (2021).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -5400bps in 2023, then soared by 7400bps in 2025.
  • Ptc Therapeutics' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then crashed by -42bps to 0.36% in 2022, then decreased by -24bps to 0.45% in 2023, then surged by 44bps to 0.25% in 2024, then skyrocketed by 273bps to 0.44% in 2025.
  • Its Return on Capital Employed was 0.44% in Q3 2025, compared to 0.36% in Q2 2025 and 0.45% in Q1 2025.